Abstract
297
Horrobin, D.F. and Manku, M.S.
Essential fatty acids in clinical medicine [review]
Nutr Health 1983; 2: 127-134.


Abstract

There are two types of essential fatty acids (EFAs), the n-6 derived from linoleic acid and the n-3 from alpha-linolenic acid. They play major roles in the structure of all organs and determine some of the properties of all membranes. The EFAs also act as precursors for the eicosanoids, the prostaglandins and leokotrienes. The body requires adequate intakes of linoleic and alpha-linolenic acids but must also be able to metabolize them normally. Abnormalities of EFA intake and absorption are exceedingly rare except in patients with known ma/absorption or who are on total parenteral nutrition Abnormalities of EFA metabolism, in contrast, appear to be rather common. Patients with a topic eczema seem to have a defect at the delta-6-desaturase level which leads to elevated blood levels of the two main dietary precursors but significantly reduced levels of all metabolites. Patients with premenstrual syndrome appear to have low n-6 metabolites and elevated n-3 metabolites, those with premenstrual breast disease to have low n-6 and near normal n-3 metabolites and those with non-cydllc breast disease to have a deficiency of both n-6 and n-3 acids. Both diabetes and alcoholism lead to defective delta-6-desaturase function and/ow concentrations of EFA metabolites. There is considerable clinical evidence that gamma-linolenic acid can correct some of the abnormalities in EFA patterns and can also lead to simultaneous clinical improvement, suggesting that the EFA abnormalities are playing a causative role. As Sinclair predicted 30 years ago, understanding of EFA metabolism seems likely to bring about major practical advances in clinical medicine.


All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact